-transparent.png){kind=logo}
The success of chemotherapy of inoperable endothoracic cancer largely depends on interdisciplinary cooperation. 30 years of research have succeeded in developing some promising combinations of cytostatic agents. Administered sequentially they are better tolerated and this has made outpatient treatment possible. 87 persons had polycytostatic therapy according to the Karrer/Sighart formula. It was followed by a difinite improvement in the general condition of the patients, but without any substantial lengthening of the average survival time. The ACO scheme (Seeber/Schmidt) has been used since April 1977 in 42 persons. Preliminary results indicate a definite prologation of survival time, especially in cases of small-cell bronchogenic carcinoma.
U Gatzemeier, and
G Jüngst, and
G Wagner
January 1981,
La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
U Gatzemeier, and
G Jüngst, and
G Wagner
March 1980,
Annales de chirurgie,
U Gatzemeier, and
G Jüngst, and
G Wagner
October 1974,
Thoraxchirurgie, vaskulare Chirurgie,
U Gatzemeier, and
G Jüngst, and
G Wagner
January 1976,
Zentralblatt fur Chirurgie,
U Gatzemeier, and
G Jüngst, and
G Wagner
January 1979,
Zentralblatt fur Chirurgie,
U Gatzemeier, and
G Jüngst, and
G Wagner
August 1978,
Deutsche medizinische Wochenschrift (1946),
U Gatzemeier, and
G Jüngst, and
G Wagner
October 1980,
Radiobiologia, radiotherapia,
U Gatzemeier, and
G Jüngst, and
G Wagner
February 1975,
Zeitschrift fur Erkrankungen der Atmungsorgane,
U Gatzemeier, and
G Jüngst, and
G Wagner
December 1978,
Wiener klinische Wochenschrift,
U Gatzemeier, and
G Jüngst, and
G Wagner
January 1981,
La Radiologia medica,
